Across rheumatic diseases

Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis

Rheumatology (Oxford)Published Systematic review and meta-analysis

Authors' conclusion

Physical activity can be lower than the recommended threshold in patients with RMDs when objectively measured using WD.

Study context

Population
Patients with noninflammatory and inflammatory rheumatic diseases whose physical activity (PA) was assessed with wearable devices51 articles
Participants
7,488 patients
Outcome
Number of steps and moderate-vigorous physical activity (MVPA), relative to recommended PA threshold
Methodological detailsrandom-effect meta-analysis, univariable meta-regression, Search of PubMed, Embase, CINAHL and Scopus, 22 studies moderate-vigorous physical activity (MVPA) only, 16 steps only, 13 both outcomes
  • Random-effect meta-analysis
  • Univariable meta-regression
  • Search of PubMed, Embase, CINAHL and Scopus
  • 22 studies MVPA only, 16 steps only, 13 both outcomes

Pooled result

As reported in the abstract

Difference from recommended PA threshold

MVPA: recommended PA threshold reached

36.35

95% CI 29.39, 43.31

Daily steps: recommended PA threshold not reached (−1640.42 to −544.77)

−1092.60

Further pooled results

Daily steps in fibromyalgia studies

Higher number of daily steps vs other rheumatic musculoskeletal disorders (RMDs) (5198.65-7381.62)
6290

Daily steps by disease category

Chronic inflammatory arthropathies seemed to fare better in daily steps than the other categories

PA by age

Younger patients reported higher overall PA than elderly for both steps and MVPA

Original publication

Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis. Rheumatology (Oxford). Published 25 August 2022. doi:10.1093/rheumatology/keac476

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.